Skip to main content
OpenTrials

Clinical trial condition

Rectal Diseases

Explore clinical trials studying Rectal Diseases. Study availability and eligibility vary by location and protocol.

5,954 public trials 1,253 recruiting studies
Refine in advanced search Browse all conditions

Rectal Diseases trial results

Active, Not Recruiting

Consolidation Chemotherapy for Locally Advanced Mid or Low Rectal Cancer After Neoadjuvant Concurrent Chemoradiotherapy

NCT02843191

Conditions
Colorectal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +9 more
Locations
  • Inje University Busan Paik hospital Busan, South Korea
  • Soonchunhyang University Cheonan Hospital Cheonan, South Korea
  • Chuncheon Sacred Heart Hospital, Hallym University College of Medicine Chuncheon, South Korea
  • Keimyung University Dongsan Medical Center Daegu, South Korea
View all 14 locations
View Trial Details
Active, Not Recruiting

Anti-PD-1 and mDCF Followed by Chemoradiotherapy in Patients With Stage III Squamous Cell Anal Carcinoma.

NCT04719988

Conditions
Anus Diseases, Anus Neoplasms, Colorectal Neoplasms, +11 more
Locations
  • Centre Hospitalier Universitaire de Besançon Besançon, France
  • Centre georges-François Leclerc Dijon, France
  • Hôpital Franco-Britannique Levallois-Perret, France
  • Centre Léon Bérard Lyon, France
View Trial Details
Active, Not Recruiting

BXQ-350 in Newly Diagnosed Metastatic Colorectal Carcinoma

NCT05322590

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +10 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • UC Irvine Health Orange, California, United States
  • Pacific Hematology Oncology Associates San Francisco, California, United States
  • Sylvester Comprehensive Cancer Center, University of Miami Hospitals and Clinics Miami, Florida, United States
View Trial Details
Active, Not Recruiting

A Phase III Study to Evaluate the Efficacy, Immunogenicity and Safety of the 9-valent HPV Vaccine in Chinese Males

NCT06465914

Conditions
AIN1, AIN2, AIN3, +45 more
Locations
  • Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention Nanning, Guangxi, China
  • Hunan Center for Disease Control and Prevention Changsha, Hunan, China
  • Shanxi Provincial Disease for Control and Prevention Taiyuan, Shanxi, China
  • Sichuan Center for Disease Control and Prevention Chengdu, Sichuan, China
View Trial Details
Active, Not Recruiting

A Study of XL092 as Single-Agent and Combination Therapy in Subjects With Solid Tumors

NCT03845166

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +27 more
Locations
  • Exelixis Clinical Site #6 Duarte, California, United States
  • Exelixis Clinical Site #49 La Jolla, California, United States
  • Exelixis Clinical Site #7 Los Angeles, California, United States
  • Exelixis Clinical Site #84 Los Angeles, California, United States
View all 86 locations
View Trial Details

Related conditions